Interest Income Expense - Mirati Therapeutics Inc (NASDAQ:MRTX) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 58.7 USD

Updated:

Mirati Therapeutics Inc
Interest Income Expense

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Mirati Therapeutics Inc
Interest Income Expense Peer Comparison

ABBV

GILD

AMGN

VRTX

REGN

Company		Interest Income Expense	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Mirati Therapeutics Inc NASDAQ:MRTX	Interest Income Expense $2.1m	CAGR 3-Years -37%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Abbvie Inc NYSE:ABBV	Interest Income Expense -$1.8B	CAGR 3-Years 8%	CAGR 5-Years -7%	CAGR 10-Years -19%
	Gilead Sciences Inc NASDAQ:GILD	Interest Income Expense -$757m	CAGR 3-Years 35%	CAGR 5-Years 0%	CAGR 10-Years -10%
	Amgen Inc NASDAQ:AMGN	Interest Income Expense -$2.9B	CAGR 3-Years -44%	CAGR 5-Years -30%	CAGR 10-Years -16%
	Vertex Pharmaceuticals Inc NASDAQ:VRTX	Interest Income Expense $563.1m	CAGR 3-Years 78%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Regeneron Pharmaceuticals Inc NASDAQ:REGN	Interest Income Expense $221.8m	CAGR 3-Years -13%	CAGR 5-Years 75%	CAGR 10-Years N/A

See Also

Based on the financial report for Sep 30, 2023, Mirati Therapeutics Inc's Interest Income Expense amounts to 2.1m USD.

The average annual Interest Income Expense growth rates for Mirati Therapeutics Inc have been -37% over the past three years .

Join more than 137,800+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.